Literature DB >> 1740140

Role of the beta subunit of casein kinase-2 on the stability and specificity of the recombinant reconstituted holoenzyme.

F Meggio1, B Boldyreff, O Marin, L A Pinna, O G Issinger.   

Abstract

Recombinant human alpha subunit from casein kinase-2 (CK-2) was subjected, either alone or in combination with recombinant human beta subunit, to high temperature, tryptic digestion and urea treatment. In all three cases, it was shown that the presence of the beta subunit could drastically reduce the loss of kinase activity, strongly suggesting a protective function for the beta subunit. Assaying different peptides for specificity toward the recombinant alpha subunit and the recombinant reconstituted enzyme, showed that the presence of the beta subunit could modify the specificity of the catalytic alpha subunit. Therefore, a dual function for the beta subunit is proposed which confers both specificity and stability to the catalytic alpha subunit within the CK-2 holoenzyme complex. The peptide DLEPDEELEDNPNQSDL, reproducing the highly acidic amino acid 55-71 segment of the human beta subunit, counteracts the stimulatory effect of the beta subunit on the alpha subunit activity and partially substitutes the beta subunit in conferring thermal stability to the alpha subunit. No such effect is induced by the peptide MSSSEEVSW, reproducing the N-terminal segment of the beta subunit including the autophosphorylation site. It is suggested that the acidic domain of the beta subunit, encompassing residues 55-71, plays a role in the interactions between the beta and alpha subunits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740140     DOI: 10.1111/j.1432-1033.1992.tb16636.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  36 in total

1.  Interactions of protein kinase CK2beta subunit within the holoenzyme and with other proteins.

Authors:  M Kusk; R Ahmed; B Thomsen; C Bendixen; O G Issinger; B Boldyreff
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  CK2, a protein kinase of the next millennium.

Authors:  G Dobrowolska; F J Lozeman; D Li; E G Krebs
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Multiple forms of protein kinase CK2 present in leukemic cells: in vitro study of its origin by proteolysis.

Authors:  J Roig; A Krehan; D Colomer; W Pyerin; E Itarte; M Plana
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  CK2alpha-protein phosphatase 2A molecular complex: possible interaction with the MAP kinase pathway.

Authors:  F Lebrin; L Bianchini; T Rabilloud; E M Chambaz; Y Goldberg
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Functional analysis of CK2beta-derived synthetic fragments.

Authors:  F Meggio; O Marin; S Sarno; L A Pinna
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

6.  Expression and regulation of protein kinase CK2 during the cell cycle.

Authors:  D G Bosc; B Lüscher; D W Litchfield
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

7.  Distinctive features of plant protein kinase CK2.

Authors:  M Riera; G Peracchia; M Pagès
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

8.  Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus.

Authors:  M Faust; M Jung; J Günther; R Zimmermann; M Montenarh
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

9.  Assembly of protein kinase CK2: investigation of complex formation between catalytic and regulatory subunits using a zinc-finger-deficient mutant of CK2beta.

Authors:  D A Canton; C Zhang; D W Litchfield
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

Review 10.  Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.

Authors:  Chandrika Gowda; Chunhua Song; Malika Kapadia; Jonathon L Payne; Tommy Hu; Yali Ding; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2016-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.